TIL therapy manufacturing

In this infographic, Cytiva addresses challenges at each stage of the TIL (Tumor-infiltrating lymphocyte) therapy manufacturing workflow. It considers the challenges of each stage and provides solutions. The workflow presented covers tumor tissue resection and transfer, tissue disaggregation and feeder cells, selection and expansion (pre-REP), TIL activation and expansion (REP), harvest and formulation, cryopreservation and shipment, and therapy delivery.